MCK McKesson Corporation
Stock · NYSE · United States · Healthcare · US58155Q1031
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by McKesson Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
1,060.84 USD
-1.04%
52-week range
723.68 – 1,121.50
Dividend yield0.35%
Market cap122.5B
NowoTrade score
62 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:42. Information, not advice.
Results
Next results
03 Feb 2027
in 87 days · 16:00 · estimate 10.91
Last results
11.68 vs 10.75 estimated
04 Nov 2026 · Beat +8.6%
Beat the estimate
9 of 12
1 missed · 2 in line · 3 beats in a row
Average surprise
+4.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Feb 2027 16:00 | 10.91 | — | — | Upcoming |
| 04 Nov 2026 16:00 | 10.75 | 11.68 | +8.6% | Beat |
| 05 Aug 2026 16:00 | 9.54 | 9.93 | +4.1% | Beat |
| 07 May 2026 16:00 | 11.57 | 11.69 | +1.1% | Beat |
| 04 Feb 2026 16:00 | 9.27 | 9.34 | +0.7% | In line |
| 05 Nov 2025 16:00 | 9.05 | 9.86 | +8.9% | Beat |
| 06 Aug 2025 16:00 | 8.15 | 8.26 | +1.4% | Beat |
| 08 May 2025 16:00 | 9.83 | 10.12 | +3.0% | Beat |
| 05 Feb 2025 16:00 | 7.99 | 8.03 | +0.5% | In line |
| 06 Nov 2024 16:00 | 6.87 | 7.07 | +2.9% | Beat |
| 07 Aug 2024 12:00 | 7.21 | 7.88 | +9.3% | Beat |
| 07 May 2024 16:00 | 6.36 | 6.18 | -2.8% | Miss |
| 07 Feb 2024 16:00 | 7.05 | 7.74 | +9.8% | Beat |
| 01 Nov 2023 16:00 | 6.15 | 6.23 | +1.3% | Beat |
| 02 Aug 2023 16:00 | 5.87 | 7.27 | +23.9% | Beat |
| 08 May 2023 16:00 | 7.12 | 7.19 | +0.9% | In line |
| 01 Feb 2023 16:00 | 6.36 | 6.90 | +8.5% | Beat |
| 01 Nov 2022 16:00 | 6.10 | 6.06 | -0.7% | In line |
| 03 Aug 2022 16:00 | 5.30 | 5.83 | +10.1% | Beat |
| 05 May 2022 16:00 | 6.04 | 5.83 | -3.6% | Miss |
| 02 Feb 2022 16:00 | 5.42 | 6.15 | +13.6% | Beat |
| 01 Nov 2021 16:00 | 4.66 | 6.15 | +32.0% | Beat |
| 03 Aug 2021 22:00 | 4.14 | 5.56 | +34.3% | Beat |
| 06 May 2021 16:00 | 5.05 | 5.05 | +0.1% | In line |
| 02 Feb 2021 07:00 | 4.13 | 4.60 | +11.4% | Beat |
| 03 Nov 2020 07:00 | 3.88 | 4.80 | +23.7% | Beat |
| 03 Aug 2020 07:00 | 2.39 | 2.77 | +16.0% | Beat |
| 20 May 2020 07:00 | 4.10 | 4.27 | +4.0% | Beat |
| 04 Feb 2020 07:00 | 3.49 | 3.81 | +9.2% | Beat |
| 30 Oct 2019 07:00 | 3.59 | 3.60 | +0.2% | In line |
| 31 Jul 2019 16:00 | 3.01 | 3.31 | +9.8% | Beat |
| 08 May 2019 07:00 | 3.66 | 3.69 | +1.0% | In line |
| 31 Jan 2019 16:00 | 3.16 | 3.40 | +7.5% | Beat |
| 25 Oct 2018 07:00 | 3.28 | 3.60 | +9.6% | Beat |
| 26 Jul 2018 07:00 | 2.89 | 2.90 | +0.3% | In line |
| 24 May 2018 07:00 | 3.57 | 3.49 | -2.1% | Miss |
| 01 Feb 2018 07:00 | 2.95 | 3.41 | +15.8% | Beat |
| 26 Oct 2017 07:00 | 2.79 | 3.28 | +17.4% | Beat |
| 27 Jul 2017 07:00 | 2.83 | 2.46 | -13.1% | Miss |
| 18 May 2017 16:00 | 3.01 | 3.42 | +13.6% | Beat |
| 25 Jan 2017 16:00 | 2.91 | 3.05 | +4.9% | Beat |
| 27 Oct 2016 16:00 | 3.05 | 2.94 | -3.5% | Miss |
| 27 Jul 2016 16:00 | 3.34 | 3.50 | +4.7% | Beat |
| 04 May 2016 16:00 | 3.03 | 3.17 | +4.8% | Beat |
| 27 Jan 2016 16:00 | 3.13 | 3.18 | +1.5% | Beat |
| 29 Oct 2015 07:00 | 2.99 | 3.31 | +10.6% | Beat |
| 29 Jul 2015 16:00 | 2.91 | 3.14 | +8.1% | Beat |
| 12 May 2015 16:00 | 2.75 | 2.94 | +7.0% | Beat |
| 05 Feb 2015 16:00 | 2.61 | 2.89 | +10.6% | Beat |
| 28 Oct 2014 16:00 | 2.73 | 2.79 | +2.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 403.4B | +12.4% | 4.8B | 1.2% | 38.38 | +49.2% | 5.4B |
| 2025 | 359.1B | +16.2% | 3.3B | 0.9% | 25.72 | +14.9% | 5.2B |
| 2024 | 309B | +11.7% | 3B | 1.0% | 22.39 | -10.5% | 3.6B |
| 2023 | 276.7B | — | 3.6B | 1.3% | 25.03 | — | 4.6B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 24 Jan 2024 | 485.69 | 488.01 | 484.25 | 485.00 | -0.08% | 496,500 | |
| 23 Jan 2024 | 484.69 | 486.78 | 483.13 | 485.37 | -0.40% | 582,800 | |
| 22 Jan 2024 | 484.52 | 490.13 | 483.32 | 487.32 | +0.56% | 777,000 | |
| 19 Jan 2024 | 493.24 | 494.30 | 484.27 | 484.60 | -1.70% | 876,800 | |
| 18 Jan 2024 | 483.83 | 494.76 | 480.14 | 493.00 | +1.48% | 789,800 | |
| 17 Jan 2024 | 489.49 | 494.76 | 485.35 | 485.82 | -0.55% | 618,700 | |
| 16 Jan 2024 | 486.51 | 489.77 | 485.01 | 488.50 | +0.66% | 510,700 | |
| 12 Jan 2024 | 487.68 | 489.73 | 484.79 | 485.32 | -0.72% | 438,800 | |
| 11 Jan 2024 | 485.00 | 489.07 | 483.99 | 488.84 | +1.06% | 590,700 | |
| 10 Jan 2024 | 482.52 | 485.91 | 479.37 | 483.69 | +0.55% | 609,300 | |
| 09 Jan 2024 | 475.39 | 483.12 | 471.18 | 481.06 | +0.93% | 904,900 | |
| 08 Jan 2024 | 480.64 | 482.63 | 470.11 | 476.63 | -0.33% | 666,900 | |
| 05 Jan 2024 | 476.88 | 479.46 | 472.49 | 478.19 | +0.77% | 579,200 | |
| 04 Jan 2024 | 476.39 | 481.76 | 474.25 | 474.55 | -1.21% | 881,300 | |
| 03 Jan 2024 | 476.24 | 485.22 | 476.24 | 480.34 | +1.46% | 1,288,000 | |
| 02 Jan 2024 | 462.70 | 473.42 | 462.70 | 473.42 | +2.25% | 739,600 | |
| 29 Dec 2023 | 459.84 | 464.35 | 457.99 | 462.98 | +1.20% | 481,300 | |
| 28 Dec 2023 | 458.30 | 461.71 | 457.24 | 457.50 | +0.00% | 414,100 | |
| 27 Dec 2023 | 455.50 | 458.00 | 454.18 | 457.49 | +0.38% | 419,100 | |
| 26 Dec 2023 | 453.19 | 456.52 | 451.54 | 455.76 | +0.34% | 470,200 | |
| 22 Dec 2023 | 454.27 | 456.95 | 450.33 | 454.20 | +0.33% | 519,800 | |
| 21 Dec 2023 | 447.25 | 453.08 | 445.06 | 452.71 | +1.51% | 559,000 | |
| 20 Dec 2023 | 450.00 | 450.16 | 445.52 | 445.96 | -0.46% | 722,400 | |
| 19 Dec 2023 | 448.25 | 449.72 | 444.51 | 448.03 | +0.11% | 848,900 | |
| 18 Dec 2023 | 443.47 | 448.43 | 441.68 | 447.54 | +1.84% | 804,500 |
Page 29 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- McKesson (MCK) Plans Medical Surgical Spin Off With $1.25 Billion Backing (opens in a new tab) Simply Wall St. · 08 Nov 2026 08:12
- McKesson Q2 Earnings Call Highlights (opens in a new tab) MarketBeat · 07 Nov 2026 16:14
- Is McKesson Stock Increasing Your Market Risk? (opens in a new tab) Trefis · 06 Nov 2026 23:26
- McKesson (MCK) Upgraded to Buy: Here's What You Should Know (opens in a new tab) Zacks · 06 Nov 2026 16:00
- McKesson Corporation (MCK) Hit a 52 Week High, Can the Run Continue? (opens in a new tab) Zacks · 06 Nov 2026 13:15
- Drug Wholesalers Go Three-For-Three In Earnings Beats, But Only Two Stocks Pop (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:24
- The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:17
- UBS Maintains Buy on McKesson, Raises Price Target to $1250 (opens in a new tab) Benzinga · 05 Nov 2026 20:58
- McKesson Corp.: Normalized Earnings Suggest Attractive Valuation (opens in a new tab) SeekingAlpha · 05 Nov 2026 18:50
- MCK Q2 Earnings Call Highlights Raised Outlook and Specialty Growth (opens in a new tab) Zacks · 05 Nov 2026 17:27
- TD Cowen Maintains Buy on McKesson, Raises Price Target to $1200 (opens in a new tab) Benzinga · 05 Nov 2026 16:31
- Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1200 (opens in a new tab) Benzinga · 05 Nov 2026 15:53
- RBC Capital Maintains Sector Perform on McKesson, Raises Price Target to $965 (opens in a new tab) Benzinga · 05 Nov 2026 15:36
- McKesson Corporation Q2 2027 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 13:30
- MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised (opens in a new tab) Zacks · 05 Nov 2026 13:00
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 1,072.00 USD
- Market cap
- 122.5B
- Dividend yield
- 0.35%
- 5-year average yield
- 0.46%
- Payout ratio
- 9%
- Last dividend
- 0.9400 USD · 01 Dec 2026
- Next ex-dividend date
- 01 Dec 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Distribution
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 01 Sep 2026 | 0.9400 USD |
| 01 Jun 2026 | 0.8200 USD |
| 02 Mar 2026 | 0.8200 USD |
| 01 Dec 2025 | 0.8200 USD |
| 02 Sep 2025 | 0.8200 USD |
| 02 Jun 2025 | 0.7100 USD |
| 03 Mar 2025 | 0.7100 USD |
| 02 Dec 2024 | 0.7100 USD |
| 30 Aug 2024 | 0.7100 USD |
| 03 Jun 2024 | 0.6200 USD |
| 29 Feb 2024 | 0.6200 USD |
| 30 Nov 2023 | 0.6200 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 1.5 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 25.0 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 15.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 7.5 / 15 | — |
| Valuation Free cash flow yield and the P/E against its sector. | 8.9 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.7 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 27.36× | Weak | 30.3× |
| P/E (forward) | 20.37× | Fair | 14.94× |
| Price / book | -30.85× | Weak | 3.81× |
| Price / sales | 0.29× | Good | 3.19× |
| EV / EBITDA | 17.82× | Weak | 12.63× |
| Free cash flow yield | 6% | Good | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 3.7% | Weak | 58.6% |
| Operating margin | 1.5% | Weak | 7.8% |
| Net margin | 1.1% | Weak | 2.8% |
| Return on assets | 4.7% | Fair | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 13.4% | Good | 10.8% |
| EPS growth / year | 15.3% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | -3.97× | Good | 0.48× |
| Net debt / EBITDA | 0.64× | Good | 1.58× |
| Interest cover | 26.13× | Good | 2.76× |
| Current ratio | 0.9× | Weak | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 8.8% | Good | 0% |
| Payout of free cash flow | 5.1% | Good | 28.9% |
| Payout of free cash flow (3 years) | 7.3% | Good | — |
| Dividend growth / year | 10.9% | Good | 7.1% |
| Years of rising dividends | 13 | Good | 3 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow MCK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.